Oncomine MDS Panel - MyeloDysplastic Syndrome
Commonly Known As:
Oncomine MDS Panel - MyeloDysplastic Syndrome
It is a next-generation sequencing test designed to identify genetic mutations associated with myelodysplastic syndromes (MDS). By analysing key genes, this panel helps evaluate MDS more accurately and can help guide personalised treatment strategies.
Test Preparation :
No Special Preparation. Informed Consent Required.
Reporting TAT :
Same Day
Specialisation(S) :
Test parameters includes :
No tests are mapped to this service.
Visit Type
Centre Visit
Are you Looking for Online Appointment?